GlassScriptPhysician profile
Michelle Liechty
NPI 1740959188
$1,120.61
in general payments reported to CMS, 2019-2025
16 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.92 · 2022: $295 · 2023: $143 · 2024: $373 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $207.93 | 2022-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $154.19 | 2022-2024 | Jornay Pm |
| Kowa Pharmaceuticals America, INC. | $124.34 | 2025 | Zoryve |
| Verrica Pharmaceuticals INC. | $122.34 | 2024 | Ycanth |
| Pfizer INC. | $110.08 | 2022-2023 | |
| Supernus Pharmaceuticals, INC. | $101.79 | 2025 | Qelbree |
| Neuraxis, INC. | $69.78 | 2024 | |
| Seqirus USA INC | $54.27 | 2022-2024 | Flucelvax, Flucelvax Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $34.75 | 2024 | |
| Sanofi-Aventis U.S. LLC | $33.65 | 2025 | |
| Ironwood Pharmaceuticals, INC | $23.54 | 2024 | |
| Sanofi Pasteur INC. | $17.78 | 2025 | |
| Glaxosmithkline, LLC. | $17.72 | 2024 | Bexsero |
| Collegium Pharmaceutical, INC. | $17.43 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $16.10 | 2023 | Vaxneuvance, Proquad, Gardasil 9 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $14.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Liechty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.